ADTALEM GLOBAL EDUCATION INC (ATGE)
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ATGE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ATGE | President and Founder, Austin Highlands Advisors, LLC; Director; Chair | 66 | ["CFO/audit function expertise", "Strategy", "Global markets", "Human capital management", "Former President, Austin Highlands Advisors, LLC", "Lead Independent Director from July 2019 through November 2022", "Executive Vice President & Chief Financial Officer of IDEV Technologies", "Executive Vice President & Chief Financial Officer of ReAble Therapeutics", "Chief Financial Officer of Cholestech Corporation", "board member of Tactile Systems Technology, Inc. since 2015", "board member of Ceribell Inc. since 2022", "board member of Nalu Medical, Inc. since 2024", "served on numerous public and private company boards", "audit committee financial expert"] | ["Ceribell, Inc.", "Tactile Systems Technology Inc.", "Audit and Finance", "Compensation", "nominating and governance"] | 2025 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TCMD | Former President, Austin Highlands Advisors, LLC; Chairman of the Board of Directors | 66 | ["President of Austin Highlands Advisors, LLC", "Executive Vice President and Chief Financial Officer of IDEV Technologies", "Executive Vice President and Chief Financial Officer of ReAble Therapeutics", "Chief Financial Officer of Cholestech Corporation", "Experience on the board of directors of numerous public and private companies"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Burke has been a director of Adtalem since January 2017. He served as our Lead Independent Director from July 2019 through November 2022. From November 2015 to June 2024, Mr. Burke served as President of Austin Highlands Advisors, LLC, a provider of corporate advisory services. He served as Executive Vice President & Chief Financial Officer of IDEV Technologies, a peripheral vascular devices company, from November 2009 until the company was acquired by Abbott Laboratories in August 2013. From August 2004 to December 2007, he served as Executive Vice President & Chief Financial Officer of ReAble Therapeutics, a diversified orthopedic device company which was sold to The Blackstone Group in a going private transaction in 2006 and subsequently merged with DJO Incorporated in November 2007. Mr. Burke remained with ReAble Therapeutics until June 2008. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation, a medical diagnostic products company. Mr. Burke has served on numerous public and private company boards including serving as a board chairman and a lead independent director. He has served on the board of Tactile Systems Technology, Inc. (NASDAQ: TCMD) since 2015 and currently serves as Chairman of the Board and as a member of its nominating and governance committee. Since 2022, he has served on the board of directors of Ceribell Inc., (NASDAQ: CBLL), a medical technology company. Mr. Burke also currently chairs Ceribell s audit committee and serves on the nominating and governance committee. In 2024, he joined the board of Nalu Medical, Inc., a privately-held, medical technology company. He previously served on the board of Invuity, Inc. (acquired by Stryker Corp. in 2018), LDR Holding Corporation (acquired by Zimmer Biomet in 2016), and Medical Action Industries (acquired by Owens & Minor in 2014).